Abstract: Systems, eye-mountable devices, and methods that facilitate chronotherapeutic treatment of primary open-angle ...
Alstom's first half 2024/25: good commercial performance, confirmation of FY 2024/25 outlook H1 2024/25 highlights: Book-to-bill ratio at 1.25 and organic sales up 5.6%1aEBIT2 of €515 million, up 18% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback